Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease

[1]  Lifu Sheng,et al.  Neural Cell Adhesion Molecule 2 Promotes the Formation of Filopodia and Neurite Branching by Inducing Submembrane Increases in Ca2+ Levels , 2015, The Journal of Neuroscience.

[2]  A. Fournier,et al.  IgLON Cell Adhesion Molecules Are Shed from the Cell Surface of Cortical Neurons to Promote Neuronal Growth* , 2014, The Journal of Biological Chemistry.

[3]  M. Schachner,et al.  The Neural Cell Adhesion Molecule Promotes Maturation of the Presynaptic Endocytotic Machinery by Switching Synaptic Vesicle Recycling from Adaptor Protein 3 (AP-3)- to AP-2-Dependent Mechanisms , 2013, The Journal of Neuroscience.

[4]  S. Kügler,et al.  Adhesion molecule L1 binds to amyloid beta and reduces Alzheimer's disease pathology in mice , 2013, Neurobiology of Disease.

[5]  R. Vassar,et al.  Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation , 2013, Molecular Neurodegeneration.

[6]  M. Schachner,et al.  The Neural Cell Adhesion Molecule (NCAM) Associates with and Signals through p21-Activated Kinase 1 (Pak1) , 2013, The Journal of Neuroscience.

[7]  M. Schachner,et al.  Lipid Raft-dependent Endocytosis of Close Homolog of Adhesion Molecule L1 (CHL1) Promotes Neuritogenesis* , 2012, The Journal of Biological Chemistry.

[8]  G. Collingridge,et al.  Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy , 2012, Molecular Neurobiology.

[9]  A. Vortmeyer,et al.  Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons , 2012, Nature Neuroscience.

[10]  D. Benson,et al.  Synapse adhesion: a dynamic equilibrium conferring stability and flexibility , 2012, Current Opinion in Neurobiology.

[11]  Ke-ping Chen,et al.  Selective Interaction of Amyloid Precursor Protein with Different Isoforms of Neural Cell Adhesion Molecule , 2012, Journal of Molecular Neuroscience.

[12]  W. Klein,et al.  Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease , 2011, Cellular and Molecular Neurobiology.

[13]  Fabiana A. Caetano,et al.  Amyloid‐beta oligomers increase the localization of prion protein at the cell surface , 2011, Journal of neurochemistry.

[14]  M. Schachner,et al.  NCAM/spectrin complex disassembly results in PSD perforation and postsynaptic endocytic zone formation. , 2011, Cerebral Cortex.

[15]  V. Berezin,et al.  Structural model and trans-interaction of the entire ectodomain of the olfactory cell adhesion molecule. , 2011, Structure.

[16]  G. Schellenberg,et al.  Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study , 2010, BMC neurology.

[17]  C. Betzel,et al.  CHL1 Is a Selective Organizer of the Presynaptic Machinery Chaperoning the SNARE Complex , 2010, PloS one.

[18]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[19]  J. Yates,et al.  Progressive accumulation of amyloid‐β oligomers in Alzheimer’s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins , 2010, The FEBS journal.

[20]  Judianne Davis,et al.  Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils , 2010, Nature Structural &Molecular Biology.

[21]  R. Jahn,et al.  The architecture of an excitatory synapse , 2010, Journal of Cell Science.

[22]  T. Südhof.  Neuroligins and neurexins link synaptic function to cognitive disease , 2008, Nature.

[23]  Olena Bukalo,et al.  Modulation of synaptic transmission and plasticity by cell adhesion and repulsion molecules. , 2008, Neuron glia biology.

[24]  M. Schachner,et al.  A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis , 2008, Nature Cell Biology.

[25]  S. Shimohama,et al.  Amyloid β inhibits ectodomain shedding of N-cadherin via down-regulation of cell-surface NMDA receptor , 2007, Neuroscience.

[26]  M. Dalva,et al.  Cell adhesion molecules: signalling functions at the synapse , 2007, Nature Reviews Neuroscience.

[27]  W. Klein,et al.  Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.

[28]  M. Schachner,et al.  The Adhesion Molecule CHL1 Regulates Uncoating of Clathrin-Coated Synaptic Vesicles , 2006, Neuron.

[29]  M. Schachner,et al.  NCAM promotes assembly and activity-dependent remodeling of the postsynaptic signaling complex , 2006, The Journal of cell biology.

[30]  A. El-Husseini,et al.  Cell adhesion molecules at the synapse. , 2006, Frontiers in bioscience : a journal and virtual library.

[31]  C. Greer,et al.  Disrupted compartmental organization of axons and dendrites within olfactory glomeruli of mice deficient in the olfactory cell adhesion molecule, OCAM , 2006, Molecular and Cellular Neuroscience.

[32]  R. Tanzi.  The synaptic Aβ hypothesis of Alzheimer disease , 2005, Nature Neuroscience.

[33]  M. Schachner,et al.  Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth , 2005, The Journal of cell biology.

[34]  Alexander E. Dityatev,et al.  Polysialylated Neural Cell Adhesion Molecule Promotes Remodeling and Formation of Hippocampal Synapses , 2004, The Journal of Neuroscience.

[35]  S. Scheff,et al.  Synaptic pathology in Alzheimer’s disease: a review of ultrastructural studies , 2003, Neurobiology of Aging.

[36]  Melitta Schachner,et al.  Neural cell adhesion molecule promotes accumulation of TGN organelles at sites of neuron-to-neuron contacts , 2002, The Journal of cell biology.

[37]  W. Klein.  Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets , 2002, Neurochemistry International.

[38]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[39]  T. Morgan,et al.  Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies , 2001, Journal of neurochemistry.

[40]  E. Masliah,et al.  Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease , 2001, Neurology.

[41]  B. Sommer,et al.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Hayashi,et al.  OCAM: A New Member of the Neural Cell Adhesion Molecule Family Related to Zone-to-Zone Projection of Olfactory and Vomeronasal Axons , 1997, The Journal of Neuroscience.

[43]  S. Antonarakis,et al.  Cloning of a novel human neural cell adhesion molecule gene (NCAM2) that maps to chromosome region 21q21 and is potentially involved in Down syndrome. , 1997, Genomics.

[44]  E. Masliah,et al.  Synaptic and neuritic alterations during the progression of Alzheimer's disease , 1994, Neuroscience Letters.

[45]  P. Maycox,et al.  Clathrin-coated vesicles in nervous tissue are involved primarily in synaptic vesicle recycling , 1992, The Journal of cell biology.

[46]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[47]  P. Altevogt,et al.  Functional cooperation between the neural adhesion molecules L1 and N- CAM is carbohydrate dependent , 1990, The Journal of cell biology.

[48]  Jane Roberts,et al.  A Practical Approach , 1963 .

[49]  William A. Eimer.  Intraneuronal Abeta42 Neuron Loss, Dystrophic Neurites, and Heterozygous BACE1 in the 5XFAD Mouse Model of Alzheimer's Disease , 2013 .

[50]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[51]  G. Schellenberg,et al.  Genome-wide association reveals genetic effects on human Abeta 42 and tau protein levels in cerebrospinal fluids : a case control study , 2010 .

[52]  T. Uema,et al.  The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. , 2007, Human molecular genetics.

[53]  W. Klein,et al.  Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  R. Tanzi.  The synaptic Abeta hypothesis of Alzheimer disease. , 2005, Nature neuroscience.

[55]  E. Masliah,et al.  Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease , 2004, Acta Neuropathologica.

[56]  M. Kirkitadze,et al.  Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. , 2003, Proceedings of the National Academy of Sciences of the United States of America.